joining again, this Thanks, you morning. all for thank our webcast once Bart. And
$XX of in including raise major XXXX, which capital on significantly sheet. our advertising our balance of Following campaign. growth million the of our initiatives, improved our embarked launch June executing We
sales substantial operating Before R&D. administrative metrics, and merger related expenses turning color detailed to for following like compensation areas: in on our and and that our Obalon stock-based to I'd the and our drove increases expenses to with some noncash the costs general marketing, provide
expense attract proven employees enhance Subsequent our is retain merger the company, and the our the height existing on metrics. that tool NASDAQ programs. staff, appropriate stock professionals listing heart out quarter, the XXXX since with we issued we the to incentive Considering or call for to these seasoned during stock-based at As and organization. stock time placed this of effective options fundraising, understanding the believe Obalon, of units business, a first is and a we it restricted throughout the to noncash compensation
at stock million expense. of recorded Of onetime XX, this relatively stock-based are of note, employment. and Between metrics a milestones funds, lookback XXXX, X-year reported the date the the provision anniversary to includes quarter charge are the for $X total compensation the and is we for important For ended compensation and attributed generally months of X expense to September note completed it vesting outlay a a charges. this specific higher-than-normal we $XX.X major onetime majority of very year the this million of considered noncash begin acquisition-related expense to
to streamline will future these our revenue, expenses offset increases the that expect strategy quarters. as build we However, minimize costs over ongoing
operational beginning XXXX, let's backdrop, our the for quarter. to for with months XX, that With and third revenue results the the quarter turn September results and ended X
September million XX, $X.X For XXXX. X revenues $X.X ended the months the ended XX, we of XXXX, reported to revenues compared months X million in September as of
decrease another our consulting growth of expenses, quarter the months XXXX of Additionally, the quarter of revenues which the to at September from the reported sequential third third XXXX, and increased attributable consecutive quarter. of is ended the to department to to for in expenses period fees, XXXX. payroll-related $X.X second XX, related We million in quarter million increased growth we gross includes profit million in merger. of compared from $X.X million the costs Obalon had The certain to sequential $X.X X% X marks XXXX which $X.X
$X.X on our of increase increased for of months for to September expenses the The ended stock-based marketing million $X.X quarter million mentioned XXXX and $XX.X and XXXX. quarter XXXX. the for is third the operating the million merger September were Total $XX.X ended to as onetime XX, Sales million million noncash to X third X compared for expenses due months previously the by charges primarily XXXX, XX, to compared compensation. for as $X.X
commercial from from expenditure the related additional expanded an advertising the increase marketing organization. expenses our mentioned and stems previously Aside in other and increased factors, from efforts
rent services well ended X $X.X General increased Obalon for XXXX. assuming $X.X and the compared and increase expenses of for Research the discussed months professional XX, and and previously months facility development were from to $XXX,XXX consulting, XXXX, the an expenses entire for XXXX. for and audit, X related were same facility the in million increase on our expenses. months amount as September X lease September XX, period to September ended to in reflects insurance in an million an legal quarter administrative payroll-related expense XXXX, expenses the for XX, as ended This $XX expenses merger, compared million
Moving X XXXX. results to of for the our first months
XXXX, XX% in revenues revenues the the and in restrictions due XXXX. during $XXX,XXX surgeries the Between to $X.X and marketing at million increase and to rise elective sales witnessing for an COVID sales. $XX.X in for internationally. compared came is sales in Our improvement we pandemic $X.X period are awareness same obesity lessened our The in million million U.S. a efforts, in revitalized increase in
as Gross million to product volume, procedural sales. revenue, U.S. the $X a reduced months $X.X X ended totaled compared million margins higher million an improved September increase ended show The international of expenses sales to September XX, gross period percentage XX, X for increased with months of for profit XXXX. higher the attributed than $X.X XXXX profit is domestic mix and which
for With the and for at our compared expenses. by our million my additional at increased same total for and ended the XX, presented on beginning spend months September period advertising Sales expenses to added the months XXXX, ended million reasoning section, for to costs The the million X same marketing XXXX. expenses X compared X national September in and payroll marketing reflects the expenses onetime XXXX XX, related as in the direct-to-consumer $X.X campaign million million XXXX. to $X.X for $XX.X came $XX.X months increase $XX.X to financial ended operating of
period $X.X with XX, X-month million Our to other in consulting, and million provided ended merger increases we XXXX. months for related X Similar professional in September $XX.X to to the administrative the above, analysis services for experienced auditing, directly Obalon. XXXX, the and legal general compared same expenses the were
research in million development and For ReShape for trial the of expense to a months XX, $XXX,XXX XXXX, as result same the pandemic. to compared due $X.X XXXX. in to The is decreased by a the largely consulting $X.X in COVID-XX our reduction X period Vest the and slowdown decrease expenses million to trials ended September clinical due clinical for the
periods million $X.X months X XX, compensation XXXX, the and expense, EBITDA of stock-based months million in items, amortization, the loss ended ended XX, warrant September other basis, XXXX. million including $X.X for to depreciation expense, and $X.X On a the adjusted same EBITDA of addition noncash million, and compared for an non-GAAP the the respectively, amongst $X.X September loss XXXX, X was for adjusted
sheet. balance the to Turning
investor Of the September to paid million. to $XX.X and of the XXXX, As million million institutional company's in and overhang cash back to of also Obalon professional investment our totaled debt $XX.X equivalents service banking and $X cash debt fees merger. note, we related an eliminate XX,
efforts seeing and scope cost in are optimize COVID, mitigation previous of strive product success future. to revenues the visibility increase relates in As With intend and significant ROI with save financials over we I quarters, Bart. and centered our our vaccinations it demand, and in continue opportunities. out now we to mentioned more greater while report in turn we revenue and stability to back we that, the to as will even the call to around place With growth
